Stock Price Quote

POLY MEDICURE LTD.

NSE : POLYMEDBSE : 531768ISIN CODE : INE205C01021Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE1386.359.8 (+0.71 %)
PREV CLOSE ( ) 1376.55
OPEN PRICE ( ) 1404.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1341
TODAY'S LOW / HIGH ( )1376.40 1407.65
52 WK LOW / HIGH ( )820.9 1573.95
NSE1385.957.3 (+0.53 %)
PREV CLOSE( ) 1378.65
OPEN PRICE ( ) 1380.00
BID PRICE (QTY) 1385.95 (32)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 31881
TODAY'S LOW / HIGH( ) 1375.15 1415.95
52 WK LOW / HIGH ( )820.3 1575
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-03 1995
Management Info
Devendra Mehta - Chairman Himanshu Baid - Managing Director
Registered Office

Address 232- B, 3rd Floor,Okhla Industrial Estate,Phase I I I,
New Delhi,
Delhi-110020

Phone 011 - 33550700 / 47317000

Email info@polymedicure.com

Website www.polymedicure.com

Registrars Details
MAS Services Ltd
T-34 , 2nd Floor,Okhla Industrial Area,Phase - II,New Delhi
Listing : BSE, NSE, MCX

NEWS

14Jul Increase In Volume
With reference to your email ref no.: L/SURV/ONL/PV/VK/2023-24/196, date..
13Jul Clarification sought from Poly Medicu
The Exchange has sought clarification from Poly Medicure Ltd on July 13,..
19Jun Increase In Volume
With reference to your e-mail ref.: L/SURV/ONL/PV/VK/2023-2024/152, date..
17Jan Poly Medicure informs about board meet
Poly Medicure has informed that a meeting of the Board of Directors of t..
30Apr Poly Medicure informs about disclosure
Poly Medicure has informed that the exchange has received the disclosure..

Financials

in Millions
QTR Jun 23 ANNUAL 23
Net Profit605.241790.44
Gross Profit 808.68 2368.26
Operating Profit 982.73007.64
Net Sales 3055.610680.45

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Centenial Surgical (BSE)
peergroup  108.38 (10.00%)
M.Cap ( in Cr)39.54
Shree Pacetronix (BSE)
peergroup  378.95 (2.42%)
M.Cap ( in Cr)136.40
Raaj Medisafe India (BSE)
peergroup  40.80 (4.99%)
M.Cap ( in Cr)44.63
GKB Ophthalmics (BSE)
peergroup  99.84 (1.02%)
M.Cap ( in Cr)50.33
Kretto Syscon (BSE)
peergroup  0.76 (-5.00%)
M.Cap ( in Cr)11.92

Shareholding Pattern

PROMOTERS 53.31%
MUTUAL FUNDS/UTI 3.27%
NON-INSTITUTION 26.83%
FI/BANKS/INSURANCE 0.78%
GOVERNMENT 0%
FII 0%

About Poly Medicure Ltd.

Poly Medicure Ltd. was incorporated in the year 1995. Its today's share price is 1386.35. Its current market capitalisation stands at Rs 13304.88 Cr. In the latest quarter, company has reported Gross Sales of Rs. 10725.88 Cr and Total Income of Rs.11043.32 Cr. The company's management includes Avinash Chandra, Alessandro Balboni, Mukulika Baid, Jugal Kishore Baid, Rishi Baid, Himanshu Baid, Ambrish Mithal, Sonal Mattoo, Amit Khosla, Sandeep Bhargava, Shailendra Raj Mehta, Prakash Chand Surana, Devendra Mehta.

It is listed on the BSE with a BSE Code of 531768 , NSE with an NSE Symbol of POLYMED and ISIN of INE205C01021. It's Registered office is at 232- B, 3rd Floor,Okhla Industrial Estate,Phase I I INew Delhi-110020, Delhi. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Doogar & Associates, MC Bhandari & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.